Carolina Infusion, LLC: TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio
Read the official notice at FDA (drug) →
Get alerts for Carolina Infusion
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Carolina Infusion, LLC
- Product
- TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936;
- Reason / hazard
- Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide within the U.S
- Recall initiated
- 2026-09-10
- Code info
- Lots: 09012026@3, BUD: 10/16/2026; 08032026@16, BUD: 9/17/2026; 08052026@8, BUD: 9/19/2026; 08072026@13, BUD: 9/21/2026.
- Product quantity
- 5.6 mLs - in patient specific syringe doses
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Ridgeland
- State
- SC
- Country
- United States
- Event id
- 99867
Free daily digest + "My products" watchlist